[Research progress on protein succination modification in cancer]

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Metabolic dysregulation is a key characteristic of cancer.
• Mutations in tricarboxylic acid (TCA) cycle enzymes lead to oncometabolite accumulation.
• Oncometabolites like fumarate impact tumor initiation, progression, and immune evasion.

Purpose of the Study:

• To review the role of protein succination modification in cancer metabolism and immune evasion.
• To explore the clinical applications of targeting protein succination modification.

Main Methods:

• Literature review of studies on fumarate accumulation and protein succination.
• Analysis of the mechanisms by which fumarate affects cellular processes.
• Examination of the link between succination modification and tumor microenvironment.

Main Results:

• Fumarate accumulation, often due to fumarate hydratase (FH) inactivation, alters mitochondrial function, DNA repair, and protein activity.
• Fumarate modifies cysteine residues on proteins, forming S-(2-succinyl)cysteine (2SC) modifications.
• Protein succination modification is implicated in tumor initiation, progression, and immune evasion.

Conclusions:

• Protein succination modification is a critical factor in cancer development and immune evasion.
• Targeting succination modification presents a promising strategy for novel cancer therapies.
• Further research into metabolic interventions for succination modification could enhance cancer treatment outcomes.